Did you know that 75% to 90% of patients with ulcerative colitis (UC) report bowel urgency and that up to 50% of patients with UC experience urgency at least once a day?

Follow 2 interactive patient cases to learn how best to identify and manage patients with hepatitis D.

Did you know that Latino/Hispanic adults with diabetes have an increased risk of diabetic retinopathy and often are vulnerable to complications of diabetes due to limited interactions with healthcare professionals?

When should you do biopsy vs genetic testing? Dr Weir leads a case discussion on the appropriate use of different diagnostic tools in kidney disease.

What is agitation in Alzheimer’s disease (AAD) and how is it diagnosed? Drs Grossberg and Kales discuss symptoms and diagnostic approaches.

Are you using continuous glucose monitoring (CGM) in your diabetes practice? Our experts discuss how easy it can be and the benefits for your patients.

When an autoimmune neuromuscular disease signals the presence of small cell carcinoma.

What key factors should you consider when deciding which rhythm control strategy is appropriate for patients with atrial fibrillation (AF)?

Aromatase inhibitors (AIs), selective estrogen receptor modulators (SERMs), and selective estrogen receptor degraders (SERDs). How do they work and when should they be added to the treatment of metastatic hormone receptor (HR)-positive breast cancer?

Dr. Parambir Dulai discusses new therapies and treatments for IBD, as well as what is on the horizon for IBD patients.

Did you know patients with Wilson disease (WD) require lifelong treatment? Learn about strategies to enhance identification and timely management of these patients.

Guideline-orientated management of immunoglobulin A nephropathy (IgAN) includes enrolling patients who remain proteinuric despite optimized standard of care in clinical trials.

Guidelines recommend continuous glucose monitoring (CGM) in all patients with type 2 diabetes (T2D) on insulin; learn how to initiate CGM and/or use CGM more effectively.

Do you know how to assess and monitor your patients' fertility?

How do cannabinoids work in the body? Drs Gidal and Vandrey discuss all you need to know about cannabinoid and cannabinoid products.

Do you know the best approaches for identifying and managing high-risk, hormone receptor positive early breast cancer?

What is the best way to manage polypharmacy and drug load in patients with epilepsy?

Even with optimal lipid lowering, cardiovascular (CV) risk is not over! Dr. Steg shares the latest data presented at the 2023 American College of Cardiology (ACC) Scientific Sessions.